register

News & Trends - Pharmaceuticals

First-ever study unveils insights into young cancer patients’ perspectives, coinciding with Bowel Cancer Awareness Month

Health Industry Hub | June 1, 2023 |

Pharma News: In a ground-breaking study marking Bowel Cancer Awareness Month, Australian researchers shed light on the challenges faced by younger individuals with bowel cancer symptoms. The research unveils a distressing reality where these patients are forced to become their own advocates, combating age bias and navigating barriers to diagnosis. The study focused on the deadliest cancer affecting individuals aged 25 to 44, shedding light on the urgent need for improved care and outcomes for this vulnerable population.

The study, led by Dr Klay Lamprell from the Australian Institute of Health Innovation at Macquarie University, mark the first-ever investigation into the perspectives of early-onset bowel cancer patients across Australia, New Zealand, and the United Kingdom. The findings underscore a common narrative shared by young people worldwide: their youth often leads to being overlooked when it comes to bowel cancer.

According to the research, younger individuals may endure a frustrating journey, seeking medical help for an average of three months to five years before receiving a diagnosis. In some cases, they may visit ten or more general practitioners in their quest for answers. Shockingly, even when presenting symptoms like blood in their stool or rectal bleeding, these patients are not promptly referred to specialists for further testing.

Compared to those diagnosed later in life, early-onset bowel cancer patients experience longer diagnostic trajectories, with a 60% increase in the time it takes to obtain a diagnosis. This delay results in missed opportunities for early detection, leading to a higher likelihood of being diagnosed in later stages of the disease. Late-stage diagnoses, in turn, heighten the need for aggressive treatments that pose unique challenges for individuals under 50, impacting their physical, psychosocial, and overall quality of life. Fertility and ostomy management are among the pressing concerns faced by this patient population.

Dr Lamprell highlighted that age bias among healthcare providers significantly influences clinical assessments, investigations conducted, and referrals given. This bias obstructs shared decision-making and exacerbates tensions between patients and healthcare professionals. The study also revealed a recurring theme of delayed diagnosis related to referrals and lengthy wait times for non-urgent colonoscopies, leading to patient dissatisfaction with general practitioners.

Another critical aspect of the research addressed the limited clinical awareness surrounding early-onset bowel cancer, adding to the challenges faced by young people seeking a diagnosis. As the global incidence of bowel cancer rises among individuals under 50, there is an urgent need for better information and clinical guidance for general practitioners in diagnosing this particular age group, according to Dr Lamprell.

Highlighting the importance of early detection, Bowel Cancer Australia CEO Julien Wiggins emphasised that younger individuals need to be vigilant about potential signs and symptoms and take prompt action. Astonishingly, 1 in 10 new bowel cancer cases now occur in people under the age of 50, a statistic that highlights the gravity of the situation. Mr Wiggins pointed out that over the past three decades, there has been a staggering 266% increase in bowel cancer incidence rates among adolescents and young adults aged 15 to 24. Individuals born after 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to those born in 1950.

These findings serve as a wake-up call for the medical community, urging increased awareness, support, and early intervention for early-onset bowel cancer. By addressing age bias, improving clinical knowledge, and providing timely referrals, healthcare professionals can work towards ensuring optimal outcomes and improved quality of life for this vulnerable patient population.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.